Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd Mikus

Showing results (181-190 of 194) with videos related to

Pageof 20
Sort By:
European Journal of Clinical Pharmacology|January 9, 2017
Who is a 'healthy subject'?-consensus results on pivotal eligibility criteria for clinical trialsKerstin Breithaupt-Groegler, Christoph Coch, Martin Coenen, et al.
Clinical Pharmacokinetics|June 7, 2020
Validation of a Drug Transporter Probe Cocktail Using the Prototypical Inhibitors Rifampin, Probenecid, Verapamil, and CimetidineSabrina T Wiebe, Thomas Giessmann, Kathrin Hohl, et al.
European Journal of Clinical Pharmacology|October 18, 2022
Oral bioavailability of microdoses and therapeutic doses of midazolam as a 2-dimensionally printed orodispersible film in healthy volunteersMareile H Breithaupt, Evelyn Krohmer, Lenka Taylor, et al.
British Journal of Clinical Pharmacology|March 22, 2023
Time course of CYP3A activity during and after metamizole (dipyrone) in healthy volunteersMareile H Breithaupt, Evelyn Krohmer, Lenka Taylor, et al.
Malaria Journal|October 10, 2006
Methylene blue for malaria in Africa: results from a dose-finding study in combination with chloroquinePeter E Meissner, Germain Mandi, Boubacar Coulibaly, et al.
Tropical Medicine & International Health : TM & IH|January 19, 2005
Safety of the combination of chloroquine and methylene blue in healthy adult men with G6PD deficiency from rural Burkina FasoGermain Mandi, Steffen Witte, Peter Meissner, et al.
BMC Cancer|August 22, 2012
Double-blind, placebo-controlled first in human study to investigate an oral vaccine aimed to elicit an immune reaction against the VEGF-Receptor 2 in patients with stage IV and locally advanced pancreatic cancerAndreas G Niethammer, Heinz Lubenau, Gerd Mikus, et al.
Clinical and Translational Science|July 23, 2022
First-in-human, randomized, double-blind, placebo-controlled, dose escalation trial of the anti-herpes simplex virus monoclonal antibody HDIT101 in healthy volunteersAntje Blank, Nicolas Hohmann, Marlen Dettmer, et al.
BMJ Open|January 4, 2022
Plasma concentration guided dosing of drugs used for the treatment of childhood leukaemias: protocol for a systematic reviewMadelé van Dyk, Chelsea Boylan, Robin Michelet, et al.
Malaria Journal|September 24, 2005
Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso [ISRCTN27290841]Peter E Meissner, Germain Mandi, Steffen Witte, et al.
Pageof 20

Showing results (181-190 of 194) with videos related to

Sort By:
Pageof 20
European Journal of Clinical Pharmacology|January 9, 2017
Who is a 'healthy subject'?-consensus results on pivotal eligibility criteria for clinical trialsKerstin Breithaupt-Groegler, Christoph Coch, Martin Coenen, et al.
Clinical Pharmacokinetics|June 7, 2020
Validation of a Drug Transporter Probe Cocktail Using the Prototypical Inhibitors Rifampin, Probenecid, Verapamil, and CimetidineSabrina T Wiebe, Thomas Giessmann, Kathrin Hohl, et al.
European Journal of Clinical Pharmacology|October 18, 2022
Oral bioavailability of microdoses and therapeutic doses of midazolam as a 2-dimensionally printed orodispersible film in healthy volunteersMareile H Breithaupt, Evelyn Krohmer, Lenka Taylor, et al.
British Journal of Clinical Pharmacology|March 22, 2023
Time course of CYP3A activity during and after metamizole (dipyrone) in healthy volunteersMareile H Breithaupt, Evelyn Krohmer, Lenka Taylor, et al.
Malaria Journal|October 10, 2006
Methylene blue for malaria in Africa: results from a dose-finding study in combination with chloroquinePeter E Meissner, Germain Mandi, Boubacar Coulibaly, et al.
Tropical Medicine & International Health : TM & IH|January 19, 2005
Safety of the combination of chloroquine and methylene blue in healthy adult men with G6PD deficiency from rural Burkina FasoGermain Mandi, Steffen Witte, Peter Meissner, et al.
BMC Cancer|August 22, 2012
Double-blind, placebo-controlled first in human study to investigate an oral vaccine aimed to elicit an immune reaction against the VEGF-Receptor 2 in patients with stage IV and locally advanced pancreatic cancerAndreas G Niethammer, Heinz Lubenau, Gerd Mikus, et al.
Clinical and Translational Science|July 23, 2022
First-in-human, randomized, double-blind, placebo-controlled, dose escalation trial of the anti-herpes simplex virus monoclonal antibody HDIT101 in healthy volunteersAntje Blank, Nicolas Hohmann, Marlen Dettmer, et al.
BMJ Open|January 4, 2022
Plasma concentration guided dosing of drugs used for the treatment of childhood leukaemias: protocol for a systematic reviewMadelé van Dyk, Chelsea Boylan, Robin Michelet, et al.
Malaria Journal|September 24, 2005
Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso [ISRCTN27290841]Peter E Meissner, Germain Mandi, Steffen Witte, et al.
Pageof 20